OpenVSafe by OpenVAERS
Search V-safe

7MM-30061-93871

2 vaccinations 2 coded responses 12 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
021 / MA
Registered
2021-04-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-08
    Registered in v-safe
  2. 2021-04-08
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-24
    Survey response — day 14, dose 1
    MedDRA: Headache — Feeling: Fair
    Free text: Headaches
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-05-22
    Health check-in — day 42, single dose
    Feeling: Good
    Adult check-in
  7. 2021-07-10
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-10-09
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-10-22
    Dose 2 — Moderna
  10. 2021-11-01
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-11-07
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-11-21
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-11-26
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-01-23
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  15. 2022-04-24
    Survey response — 6 months, dose 2
    MedDRA: COVID-19, Unevaluable event — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Contracted a moderate case of Covid · Healthcare visit (other): Antibody treatment
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-04-24
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  17. 2022-04-26
  18. 2022-04-28
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-04-08Janssen/Johnson & Johnson
22021-10-22Moderna No

Call center

ReportedOutcomeVAERS-related outcome
2022-04-24 Successful
2022-04-28
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 7 — day 14, dose 1

2021-04-24

Symptoms: Headaches

Release 11 — 6 months, dose 2

2022-04-24

Symptoms: Contracted a moderate case of Covid
Healthcare visit (other): Antibody treatment

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDCOVID-19 · · ✓
SDHeadache ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…